International News

Five questions for Friedrich Buck, who is responsible for Geistlich's "Scientific Education" with his team. He himself is a dentist with many years of…

Geistlich Pharma's Surgery business unit becomes the exclusive distribution partner for the NUsurface® meniscus implant in Switzerland and enters into…

Last weekend Geistlich once again called for the "Geistlich Charity Walk & Run". The employees came in droves: Participants around the world ran for a…

This summer, three apprentices at Geistlich successfully obtained their Swiss Federal Certificate of Competence (EFZ). We are proud and congratulate…

Having started at Geistlich from the beginning of 2021, Dr. Ralf Halbach took the helm as CEO from July. We review his first few months in the company…

As of July 1, 2021, the management of Geistlich Pharma will be newly formed. Paul Note will hand over the controls to his successor Ralf Halbach. Rolf…

Seven questions about MEFISTO, a Horizon 2020 EU project in which Geistlich is the coordinator of the overall project as well as a scientific partner.…

As of today, Geistlich Biomaterials' "The New Daily Practice" website is live!

The new Geistlich podcast is here. It accompanies you on the journey to our in-house research & development. Immerse yourself in the world of…

After a global slump in sales due to the coronavirus pandemic, Geistlich Pharma rebounded quickly across the board from the middle of the year. The…

Out of the 6,000 people who participated in “Geistlich + YOU2”, 1,050 actively took part in the virtual hands-on workshop given by Prof. Dr. Ronald E.…

Geistlich Pharma has been granted Breakthrough Device Designation for Chondro-Gide® by the US Food and Drug Administration (FDA). Chondro-Gide® is a…

Over 6000 specialists in dentistry have benefited from the knowledge of top-class, international experts. The online congress focused on offering…

People from 100 nations will be attending this congress and you can be right at the heart of it too. Taking part in “Geistlich + YOU2” will allow you…

In January 2021, Ralf P. Halbach has taken up the position as designated CEO at Geistlich Pharma. As of July 1, 2021, he will officially take over…

After a long run of 3,988 kilometers, Geistlich Pharma’s annual donation found its destiny – Geistlich handed it over in São Paulo to the non-profit…

After the first event received an overwhelmingly positive response from more than 8,500 participants, the “Geistlich + YOU” online congress is back…

Juerg Roth has been CFO at Geistlich Pharma since August. He started his career at the regeneration expert nine years ago. Since then he has mastered…

Complex wounds do not heal easily: This is where our highly refined Advanced Wound Matrix Geistlich Derma-Gide® can provide clinical benefits to those…

325 employees of Geistlich Pharma were involved worldwide in the "Geistlich Charity Walk & Run" for the good cause. Running, walking and hiking they…